PMID- 28862119
OWN - NLM
STAT- MEDLINE
DCOM- 20180301
LR  - 20180301
IS  - 1221-9118 (Print)
IS  - 1221-9118 (Linking)
VI  - 112
IP  - 4
DP  - 2017 Jul-Aug
TI  - Management of Breast Cancer Locoregional Recurrence.
PG  - 429-435
LID - 9 [pii]
LID - 10.21614/chirurgia.112.4.429 [doi]
AB  - Breast cancer recurrence represents a challenge for clinicians because the 
      management is not standardized and usually requires a multidisciplinary approach. 
      This is the key for a good long term disease control and for a management with 
      curative intent. The local recurrence in breast cancer appears after breast 
      conserving treatment (BCT) or after mastectomy, and the regional recurrence 
      involves the ipsilateral axillary, internal mammary or supraclavicular lymph 
      nodes. Local recurrence prognosis after BCT seems to be better than after 
      mastectomy regarding distant metastases occurrence and overall survival. 
      Prognosis of axillary recurrence is better than prognosis of supraclavicular and 
      internal mammary recurrence. Locoregional recurrence in breast cancer represents 
      rather a marker for the appearance of distant metastases than a determinant 
      factor for them. Management options for locoregional recurrence of cancer require 
      multidisciplinary input decision making and for this reason the multidisciplinary 
      tumor-board (MTD) is very important. Each patient should receive the best 
      individualized oncologic treatment.
CI  - Celsius.
FAU - Voinea, Silviu Cristian
AU  - Voinea SC
FAU - Sandru, Angela
AU  - Sandru A
FAU - Blidaru, Alexandru
AU  - Blidaru A
LA  - eng
PT  - Journal Article
PT  - Review
PL  - Romania
TA  - Chirurgia (Bucur)
JT  - Chirurgia (Bucharest, Romania : 1990)
JID - 9213031
SB  - IM
MH  - Breast Neoplasms/pathology/*surgery
MH  - Female
MH  - Humans
MH  - Interdisciplinary Communication
MH  - Mastectomy/adverse effects
MH  - Mastectomy, Segmental/*adverse effects
MH  - Neoplasm Recurrence, Local/etiology/*pathology/radiotherapy/*surgery
MH  - Neoplasm Staging
MH  - Prognosis
MH  - Risk Factors
MH  - Treatment Outcome
OTO - NOTNLM
OT  - locoregionalrecurrence
OT  - markerofdistantmetastases
OT  - multimodalitytreatment
EDAT- 2017/09/02 06:00
MHDA- 2018/03/02 06:00
CRDT- 2017/09/02 06:00
PHST- 2017/08/01 00:00 [accepted]
PHST- 2017/09/02 06:00 [entrez]
PHST- 2017/09/02 06:00 [pubmed]
PHST- 2018/03/02 06:00 [medline]
AID - 9 [pii]
AID - 10.21614/chirurgia.112.4.429 [doi]
PST - ppublish
SO  - Chirurgia (Bucur). 2017 Jul-Aug;112(4):429-435. doi: 
      10.21614/chirurgia.112.4.429.